These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16724334)

  • 21. Skin alteration and convective solvent flow effects during iontophoresis. II. Monovalent anion and cation transport across human skin.
    Sims SM; Higuchi WI; Srinivasan V
    Pharm Res; 1992 Nov; 9(11):1402-9. PubMed ID: 1475225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
    Tratta E; Pescina S; Padula C; Santi P; Nicoli S
    Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flux enhancement effects of ionic surfactants upon passive and electroosmotic transdermal transport.
    Peck KD; Hsu J; Li SK; Ghanem AH; Higuchi WI
    J Pharm Sci; 1998 Sep; 87(9):1161-9. PubMed ID: 9724571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the transport pathways induced during low to moderate voltage iontophoresis in human epidermal membrane.
    Li SK; Ghanem AH; Peck KD; Higuchi WI
    J Pharm Sci; 1998 Jan; 87(1):40-8. PubMed ID: 9452966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic studies of flux variability of neutral and ionic permeants during constant current dc iontophoresis with human epidermal membrane.
    Li SK; Higuchi WI; Kochambilli RP; Zhu H
    Int J Pharm; 2004 Apr; 273(1-2):9-22. PubMed ID: 15010125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir.
    Xu Q; Ibrahim SA; Higuchi WI; Li SK
    Int J Pharm; 2009 Mar; 369(1-2):105-13. PubMed ID: 19041698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
    Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms involved in iontophoretic transport of angiotensin.
    Clemessy M; Couarraze G; Bevan B; Puisieux F
    Pharm Res; 1995 Jul; 12(7):998-1002. PubMed ID: 7494820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of electroporation on the electroosmosis across hairless mouse skin in vitro.
    Tokumoto S; Mori K; Higo N; Sugibayashi K
    J Control Release; 2005 Jul; 105(3):296-304. PubMed ID: 15894395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced transdermal delivery of 5-aminolevulinic acid and a dipeptide by iontophoresis.
    Krishnan G; Roberts MS; Grice J; Anissimov YG; Benson HA
    Biopolymers; 2011; 96(2):166-71. PubMed ID: 20665477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis.
    Hao J; Li SK
    J Pharm Sci; 2008 Feb; 97(2):893-905. PubMed ID: 17683062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transscleral passive and iontophoretic transport: theory and analysis.
    Li SK; Hao J
    Expert Opin Drug Deliv; 2018 Mar; 15(3):283-299. PubMed ID: 29149574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iontophoretic transport of oligonucleotides across human epidermal membrane: a study of the Nernst-Planck model.
    Li SK; Ghanem AH; Teng CL; Hardee GE; Higuchi WI
    J Pharm Sci; 2001 Jul; 90(7):915-31. PubMed ID: 11458339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Numerical simulation of iontophoresis for in-silico prediction of transdermal drugs in the dermal layers using skin impedance values.
    Bora DJ; Dasgupta R
    Comput Methods Programs Biomed; 2022 Feb; 214():106551. PubMed ID: 34864336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1.
    Dubey S; Kalia YN
    J Control Release; 2011 Jun; 152(3):356-62. PubMed ID: 21397646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pore charge distribution considerations in human epidermal membrane electroosmosis.
    Li SK; Ghanem AH; Higuchi WI
    J Pharm Sci; 1999 Oct; 88(10):1044-9. PubMed ID: 10514354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convective solvent flow across the skin during iontophoresis.
    Kim A; Green PG; Rao G; Guy RH
    Pharm Res; 1993 Sep; 10(9):1315-20. PubMed ID: 8234169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transepidermal transport enhancement of insulin by lipid extraction and iontophoresis.
    Rastogi SK; Singh J
    Pharm Res; 2002 Apr; 19(4):427-33. PubMed ID: 12033375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.